ATE239722T1 - Benzofurylpiperazine als serotonin-agonisten - Google Patents

Benzofurylpiperazine als serotonin-agonisten

Info

Publication number
ATE239722T1
ATE239722T1 AT00948746T AT00948746T ATE239722T1 AT E239722 T1 ATE239722 T1 AT E239722T1 AT 00948746 T AT00948746 T AT 00948746T AT 00948746 T AT00948746 T AT 00948746T AT E239722 T1 ATE239722 T1 AT E239722T1
Authority
AT
Austria
Prior art keywords
benzofurylpiperazine
serotonin agonists
serotonin
agonists
benzofurans
Prior art date
Application number
AT00948746T
Other languages
English (en)
Inventor
Karin Briner
Timothy Paul Burkholder
Mark Louis Heiman
David Lloyd Garver Nelson
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of ATE239722T1 publication Critical patent/ATE239722T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT00948746T 1999-07-29 2000-07-21 Benzofurylpiperazine als serotonin-agonisten ATE239722T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US14628799P 1999-07-29 1999-07-29
US17216999P 1999-12-17 1999-12-17
PCT/US2000/019545 WO2001009123A1 (en) 1999-07-29 2000-07-21 Benzofurylpiperazine serotonin agonists

Publications (1)

Publication Number Publication Date
ATE239722T1 true ATE239722T1 (de) 2003-05-15

Family

ID=26843756

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00948746T ATE239722T1 (de) 1999-07-29 2000-07-21 Benzofurylpiperazine als serotonin-agonisten

Country Status (11)

Country Link
US (1) US6638936B1 (de)
EP (1) EP1204658B1 (de)
JP (1) JP2003506370A (de)
AT (1) ATE239722T1 (de)
AU (1) AU6220300A (de)
CA (1) CA2380531A1 (de)
DE (1) DE60002583T2 (de)
DK (1) DK1204658T3 (de)
ES (1) ES2198329T3 (de)
PT (1) PT1204658E (de)
WO (1) WO2001009123A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2378878A1 (en) * 1999-07-29 2001-02-08 Jeffrey Thomas Mullaney Benzofurylpiperazines and benzofurylhomopiperazines: serotonin agonists
JP4204315B2 (ja) 2000-11-20 2009-01-07 ビオヴィトルム・アクチボラゲット(プブリクト) セロトニン5−ht2レセプターのアンタゴニストとしてのピペラジニルピラジン化合物
SE0004245D0 (sv) 2000-11-20 2000-11-20 Pharmacia Ab Novel compounds and their use
US7504395B2 (en) * 2001-07-20 2009-03-17 Psychogenics, Inc. Treatment for attention-deficit hyperactivity disorder
BR0311970A (pt) 2002-06-19 2005-03-29 Biovitrum Ab Novos compostos, seu uso e preparação
JP5173190B2 (ja) 2004-08-25 2013-03-27 武田薬品工業株式会社 腹圧性尿失禁の予防・治療剤及びそのスクリーニング方法
JP5528699B2 (ja) 2006-05-16 2014-06-25 武田薬品工業株式会社 縮合複素環化合物およびその用途
TW200823187A (en) * 2006-10-24 2008-06-01 Wyeth Corp Benzodioxane derivatives and uses thereof
JP5520051B2 (ja) 2007-11-15 2014-06-11 武田薬品工業株式会社 縮合ピリジン誘導体およびその用途
WO2011071136A1 (ja) 2009-12-11 2011-06-16 アステラス製薬株式会社 線維筋痛症治療剤
WO2015066344A1 (en) 2013-11-01 2015-05-07 Arena Pharmaceuticals, Inc. 5-ht2c receptor agonists and compositions and methods of use
WO2019131902A1 (ja) 2017-12-27 2019-07-04 武田薬品工業株式会社 腹圧性尿失禁および便失禁の治療薬
CN112773898A (zh) * 2019-11-11 2021-05-11 广州华真医药科技有限公司 磷酸二酯酶5抑制剂在制备抗纤维化疾病药物中的应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0006524A1 (de) * 1978-06-22 1980-01-09 Ciba-Geigy Ag Neue Tetrahydropyridin- und Piperidinderivate und deren Säureadditionssalze, Verfahren zu deren Herstellung und solche enthaltende pharmazeutische Zusammensetzungen
ATE81975T1 (de) * 1984-12-21 1992-11-15 Duphar Int Res Arzneimittel mit psychotroper wirkung.
JPH09503773A (ja) * 1993-10-19 1997-04-15 スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー 5ht−1dレセプター拮抗剤用のベンズアニリド誘導体
US5698766A (en) 1995-04-05 1997-12-16 The Regents Of The University Of California Transgenic animal model for testing drugs for treating eating disorders and epilepsy
GB9517559D0 (en) * 1995-08-26 1995-10-25 Smithkline Beecham Plc Novel compounds
PT889889E (pt) 1996-03-29 2007-01-31 Duphar Int Res Composto de piperazina e piperidina
US6132538A (en) 1998-07-30 2000-10-17 Autoliv Development Ab High gas yield generant compositions
GB0012165D0 (en) 2000-05-20 2000-07-12 Team Consulting Ltd Portable device with consistent power output

Also Published As

Publication number Publication date
JP2003506370A (ja) 2003-02-18
CA2380531A1 (en) 2001-02-08
DE60002583D1 (de) 2003-06-12
DK1204658T3 (da) 2003-09-01
PT1204658E (pt) 2003-08-29
AU6220300A (en) 2001-02-19
ES2198329T3 (es) 2004-02-01
DE60002583T2 (de) 2004-03-25
US6638936B1 (en) 2003-10-28
WO2001009123A1 (en) 2001-02-08
EP1204658A1 (de) 2002-05-15
EP1204658B1 (de) 2003-05-07

Similar Documents

Publication Publication Date Title
NL300877I2 (nl) obeticholzuur
ATE297910T1 (de) Retinoid x rezeptormodulatoren
BR0114045A (pt) Poliarilcarboxamidas úteis como agentes redutores de lipìdeos
DK1204654T3 (da) Benzofurylpiperaziner og benzofurylhomopiperaziner: Serotonin agonister
TR200200579T2 (tr) Amino-tirazolpiridin türevleri.
ATE283253T1 (de) Substituierte aminopropoxyarylderivate als lxr agonisten
ATE506354T1 (de) Substituierte arylcyclopropylacetamide als glucokinaseaktivatoren
HRP20090162T1 (en) Quinolinone-carboxamide compounds as 5-ht4 receptor agonists
ATE302775T1 (de) Carbolinderivate
DE60121461D1 (de) Kondensierte pyridoindolderivate
ATE300543T1 (de) Kondensierte pyrazindionderivate als pde5 inhibitore
EA200300619A1 (ru) Серотонинергические средства
DE602004009200D1 (de) Tetrahydrochinazolinderivate als cfr-antagonisten
EA200400073A1 (ru) Пирролопиримидины как ингибиторы протеинкиназы
PT1204658E (pt) Agonistas benzofurilpiperazina de serotonina
DE60112960D1 (de) Kondensierte pyridoindolderivate
ATE333457T1 (de) Zyklische gmp-spezifische phosphodiesteraseinhibitoren
BR0208812A (pt) Derivados fenil heterociclil éter como inibidores de recaptação de serotonina
DE60121048D1 (de) PYRAZINOi1'2':1,6öPYRIDOi3,4-BöINDOLDERIVATE
PT1204659E (pt) Benzofuranos serotoninergicos
DE60110124D1 (de) Kondensierte pyrazindionderivate als pde inhibitoren
DE60107832D1 (en) Chromenylmethylpyrimidindiamine als antibakterielle wirkstoffe
UA41350C2 (uk) Похідна морфоліну або її фармацевтично прийнятна сіль та фармацевтична композиція на її основі
DE60227113D1 (de) Kondensierte camptothecine als antitumormittel
ATE243695T1 (de) 5-bicycloindolverbindungen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1204658

Country of ref document: EP

REN Ceased due to non-payment of the annual fee